Evolution of clinical trial endpoints in chronic myeloid leukemia: efficacious therapies require sensitive monitoring techniques. [electronic resource]
Producer: 20120618Description: 664-71 p. digitalISSN:- 1873-5835
- Biomarkers, Tumor -- analysis
- Clinical Trials as Topic -- trends
- Endpoint Determination -- trends
- Humans
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- diagnosis
- Medical Oncology -- methods
- Models, Biological
- Monitoring, Physiologic -- methods
- Prognosis
- Sensitivity and Specificity
- Treatment Outcome
No physical items for this record
Publication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.